Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Keurig Dr Pepper Inc. Common Stock (KDP) Price & Performance

Heron Therapeutics IncTrade
Keurig Dr Pepper Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Keurig Dr Pepper Inc. Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.4 (market cap $68.01M), while Keurig Dr Pepper Inc. Common Stock trades at $31.15 (market cap $42.54B). The key difference: Keurig Dr Pepper Inc. Common Stock is far larger — about 625.5× Heron Therapeutics Inc's market cap, and Keurig Dr Pepper Inc. Common Stock pays a 2.94% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Keurig Dr Pepper Inc. Common Stock for 0 Days on average.

HRTXKDP
Market Cap
$68.01M$42.54B
Volume
1,891,94114,530,234
Sector
HealthConsumer Staples
52-Week High
$1.49$33.50
52-Week Low
$0.27$25.31
Typical Hold Time
35 Days0 Days
Enterprise Value
$174.75M$71.00B
Dividend Yield
—2.94%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.

The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.

Keurig Dr Pepper Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
KDP
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Keurig Dr Pepper Inc. Common Stock

Keurig Dr Pepper produces and distributes coffee, soft drinks, juices, and other beverages. It also operates the Keurig single-serve coffee system.

Read more on KDP →